These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6456681

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men.
    Føgh M, Corker CS, Hunter WM, McLean H, Philip J, Schou G, Skakkebaek NE.
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):545-52. PubMed ID: 474042
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C.
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [Abstract] [Full Text] [Related]

  • 6. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
    Bain J, Rachlis V, Robert E, Khait Z.
    Contraception; 1980 Apr; 21(4):365-79. PubMed ID: 6771093
    [Abstract] [Full Text] [Related]

  • 7. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC, Jouannet P, Marson J, Soumah A.
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [Abstract] [Full Text] [Related]

  • 8. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM, Gow SM, Wu FC.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [Abstract] [Full Text] [Related]

  • 9. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [Abstract] [Full Text] [Related]

  • 10. The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders.
    Jeffcoate WJ, Matthews RW, Edwards CR, Field LH, Besser GM.
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):189-95. PubMed ID: 6777092
    [Abstract] [Full Text] [Related]

  • 11. Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.
    Rost A, Schmidt-Gollwitzer M, Hantelmann W, Brosig W.
    Prostate; 1981 Aug; 2(3):315-22. PubMed ID: 6458025
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of spermatozoa maturation in rhesus monkey by cyproterone acetate.
    Kaur J, Ramakrishnan PR, Rajalakshmi M.
    Contraception; 1990 Sep; 42(3):349-59. PubMed ID: 2149698
    [Abstract] [Full Text] [Related]

  • 13. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [Abstract] [Full Text] [Related]

  • 14. The influence of pharmaceutical compounds on male fertility.
    Neumann F, Diallo FA, Hasan SH, Schenck B, Traore I.
    Andrologia; 1976 Nov; 8(3):203-35. PubMed ID: 793446
    [Abstract] [Full Text] [Related]

  • 15. Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.
    Cunha FS, Domenice S, Sircili MHP, Mendonca BB, Costa EMF.
    Clinics (Sao Paulo); 2018 Nov; 73():e86. PubMed ID: 29723345
    [Abstract] [Full Text] [Related]

  • 16. Effects of cyproterone acetate with combination of testosterone enanthate on seminal characteristics, androgenicity and clinical chemistry in langur monkey.
    Lohiya NK, Sharma OP.
    Contraception; 1983 Dec; 28(6):575-86. PubMed ID: 6232111
    [Abstract] [Full Text] [Related]

  • 17. Gonadotropins, testosterone and prolactin in men with abnormal semen findings and an evaluation of the hormone profile.
    Abramsson L, Duchek M.
    Int Urol Nephrol; 1989 Dec; 21(5):499-510. PubMed ID: 2515164
    [Abstract] [Full Text] [Related]

  • 18. Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers.
    Koch UJ, Lorenz F, Danehl K, Ericsson R, Hasan SH, Keyserlingk DV, Lübke K, Mehring M, Römmler A, Schwartz U, Hammerstein J.
    Contraception; 1976 Aug; 14(2):117-35. PubMed ID: 949890
    [Abstract] [Full Text] [Related]

  • 19. The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women.
    Lunell NO, Zador G, Carlström K, Eneroth P, Patek E, Wager J.
    Acta Endocrinol (Copenh); 1982 May; 100(1):91-7. PubMed ID: 6214134
    [Abstract] [Full Text] [Related]

  • 20. Gossypol as oral contraceptive for male: trial case report.
    Hoshiai H, Uehara S, Mori R, Nagaike F, Tsuiki A, Suzuki M.
    Tohoku J Exp Med; 1982 Nov; 138(3):275-80. PubMed ID: 6818716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.